IO Biotech Inc (IOBT)
0.8538
-0.12
(-11.98%)
USD |
NASDAQ |
Nov 14, 16:00
0.88
+0.03
(+3.07%)
After-Hours: 20:00
IO Biotech Total Assets (Quarterly): 111.47M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 111.47M |
| March 31, 2024 | 128.16M |
| December 31, 2023 | 150.72M |
| September 30, 2023 | 172.55M |
| June 30, 2023 | 117.56M |
| March 31, 2023 | 136.84M |
| December 31, 2022 | 151.80M |
| Date | Value |
|---|---|
| September 30, 2022 | 162.16M |
| June 30, 2022 | 182.64M |
| March 31, 2022 | 202.17M |
| December 31, 2021 | 222.29M |
| September 30, 2021 | 52.04M |
| June 30, 2021 | 58.53M |
| December 31, 2020 | 5.653M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.653M
Minimum
Dec 2020
222.29M
Maximum
Dec 2021
132.47M
Average
143.78M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.20M |
| Shareholders Equity (Quarterly) | 96.27M |